Cetuximab
CAS No. | 205923-56-4 | Cat. No. | BCP02158 |
Name | Cetuximab | ||
Synonyms | C 225;EGFR antibody;IMC 225;IMC-C 225; | ||
Formula | C6484H10042N1732O2023S36 | M. Wt | 145781.6 |
Description | Cetuximab is an epidermal growth factor receptor (EGFR) inhibitor used for the treatment of metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer. | ||
Pathways | Angiogenesis/Protein Tyrosine Kinase Jak/Stat Pathway | ||
Targets | EGFR |
Structure

Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.